Coherus BioSciences
CHRS
#8873
Rank
โ‚น13.06 B
Marketcap
โ‚น108.11
Share price
-2.44%
Change (1 day)
-24.89%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2025 (TTM): โ‚น7.20 Billion

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM ) is โ‚น7.52 Billion. In 2024 the company made a revenue of โ‚น6.24 Billion a decrease over the revenue in the year 2023 that were of โ‚น21.41 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น7.20 B15.31%
2024 โ‚น6.24 B-70.84%
2023 โ‚น21.41 B22.63%
2022 โ‚น17.46 B-28.15%
2021 โ‚น24.30 B-30.15%
2020 โ‚น34.79 B37.05%
2019 โ‚น25.39 B
2018 N/A-100%
2017 โ‚น99.35 M-99.23%
2016 โ‚น12.91 B547.1%
2015 โ‚น1.99 B1.27%
2014 โ‚น1.97 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
โ‚น10.42 B 38.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚น33.6 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.240 T 42,943.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น63.77 B 747.08%๐Ÿ‡บ๐Ÿ‡ธ USA